Vitamin D receptor signaling inhibits atherosclerosis in Mice

Molecular Endocrinology

Volumn 26, Issue 7, 2012, Pages 1091-1101

  Szeto, Frances L ^a   Reardon, Catherine A ^a   Yoon, Dosuk ^a   Wang, Youli ^a   Wong, Kari E ^a   Chen, Yunzi ^a   Kong, Juan ^a,b   Liu, Shu Q ^c   Thadhani, Ravi ^d   Getz, Godfrey S ^a   Li, Yan Chun ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b CHINA MEDICAL UNIVERSITY   (China)

^c Department of Biomedical Engineering ^*  (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALISKIREN; CELL ADHESION MOLECULE; CHOLESTEROL; CYTOKINE; LOW DENSITY LIPOPROTEIN RECEPTOR; RAG1 PROTEIN; RENIN; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; B LYMPHOCYTE; CHOLESTEROL TRANSPORT; DISEASE SEVERITY; GENE DELETION; MACROPHAGE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UPREGULATION;

AMIDES; ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA; ATHEROSCLEROSIS; B-LYMPHOCYTES; BONE MARROW CELLS; CELL ADHESION MOLECULES; CHOLESTEROL; FUMARATES; HOMEODOMAIN PROTEINS; LIPIDS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, CALCITRIOL; RECEPTORS, LDL; RENIN; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; UP-REGULATION;

MUS;

EID: 84863318938     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2011-1329     Document Type: Article

References (62)

1. Glass CK, Witztum JL 2001 Atherosclerosis. the road ahead. Cell 104:503-516
2. Ross R 1999 Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126
3. Hynes RO, Wagner DD 1996 Genetic manipulation of vascular adhesion molecules in mice. J Clin Invest 98:2193-2195
4. Galkina E, Ley K 2007 Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 27:2292-2301
5. Eriksson EE 2003 Leukocyte recruitment to atherosclerotic lesions, a complex web of dynamic cellular and molecular interactions. Curr Drug Targets Cardiovasc Haematol Disord 3:309-325
6. Dong ZM, Chapman SM, Brown AA, Frenette PS, Hynes RO, Wagner DD 1998 The combined role of P- and E-selectins in atherosclerosis. J Clin Invest 102:145-152
7. Collins RG, Velji R, Guevara NV, Hicks MJ, Chan L, Beaudet AL 2000 P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipopro-tein E-deficient mice. J Exp Med 191:189-194
8. Rajavashisth T, Qiao JH, Tripathi S, Tripathi J, Mishra N, Hua M, Wang XP, Loussararian A, Clinton S, Libby P, Lusis A 1998 Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest 101:2702-2710
9. Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, Miyata M 1995 Decreased atherosclerosis in mice deficient in both macro-phage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci USA 92:8264-8268
10. Qiao JH, Tripathi J, Mishra NK, Cai Y, Tripathi S, Wang XP, Imes S, Fishbein MC, Clinton SK, Libby P, Lusis AJ, Rajavashisth TB 1997 Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice. Am J Pathol 150:1687-1699
11. Pennings M, Meurs I, Ye D, Out R, Hoekstra M, Van Berkel TJ, Van Eck M 2006 Regulation of cholesterol homeostasis in macro-phages and consequences for atherosclerotic lesion development. FEBS Lett 580:5588-5596
12. Daugherty A, Webb NR, Rateri DL, King VL 2005 Thematic review series: the immune system and atherogenesis. Cytokine regulation of macrophage functions in atherogenesis. J Lipid Res 46: 1812-1822
13. Daugherty A, Rateri DL, Lu H, Inagami T, Cassis LA 2004 Hyper-cholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation 110:3849-3857
14. Potter DD, Sobey CG, Tompkins PK, Rossen JD, Heistad DD 1998 Evidence that macrophages in atherosclerotic lesions contain an-giotensin II. Circulation 98:800-807
15. Iwai N, Inagami T, Ohmichi N, Kinoshita M 1996 Renin is expressed in rat macrophage/monocyte cells. Hypertension 27(3 Pt 1):399-403
16. Okamura A, Rakugi H, Ohishi M, Yanagitani Y, Takiuchi S, Mori-guchi K, Fennessy PA, Higaki J, Ogihara T 1999 Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages. J Hypertens 17:537-545
17. Lu H, Rateri DL, Feldman DL, Jr RJ, Fukamizu A, Ishida J, Oes-terling EG, Cassis LA, Daugherty A 2008 Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice. J Clin Invest 118:984-993
18. Holick MF 2007 Vitamin Ddeficiency.NEnglJMed 357:266-281
19. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW 1998 The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13:325-349
20. Li YC 2011 Molecular mechanism of vitamin D in the cardiovascular system. J Investig Med 59:868-871
21. Lai H, Fishman EK, Gerstainblith G, Brinker JA, Tong W, Bhatia S, Detrick B, Lai S 2011 Vitamin D deficiency is associated with sig-nificant coronary stenoses in asymptomatic African American chronic cocaine users. Int. J Cardiol. 10.1016/j.ijcard.2011.01.032
22. Reis JP, von Mühlen D, Michos ED, Miller III ER, Appel LJ, Ara-neta MR, Barrett-Connor E 2009 Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. Atherosclerosis 207: 585-590
23. de Boer IH, Kestenbaum B, Shoben AB, Michos ED, Sarnak MJ, Siscovick DS 2009 25-Hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol 20:1805-1812
24. Oh J, Weng S, Felton SK, Bhandare S, Riek A, Butler B, Proctor BM, Petty M, Chen Z, Schechtman KB, Bernal-Mizrachi L, Bernal-Mizrachi C 2009 1,25(OH)2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 120:687-698
25. Takeda M, Yamashita T, Sasaki N, Nakajima K, Kita T, Shinohara M, Ishida T, Hirata K 2010 Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions. Arterioscler Thromb Vasc Biol 30:2495-2503
26. Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, De-may MB 1997 Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA 94:9831-9835
27. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP 2002 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110:229-238
28. Reardon CA, Blachowicz L, White T, Cabana V, Wang Y, Lukens J, Bluestone J, Getz GS 2001 Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 21:1011-1016
29. Wong KE, Szeto FL, Zhang W, Ye H, Kong J, Zhang Z, Sun XJ, Li YC 2009 Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins. Am J Physiol Endocrinol Metab 296:E820-E828
30. Zhang Z, Sun L, Wang Y, Ning G, Minto AW, Kong J, Quigg RJ, Li YC 2008 Renoprotective role of the vitamin D receptor in diabetic nephropathy. Kidney Int 73:163-171
31. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE 1992 RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68:869-877
32. Yuan W, Pan W, Kong J, Zheng W, Szeto FL, Wong KE, Cohen R, Klopot A, Zhang Z, Li YC 2007 1,25-Dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem 282:29821-29830
33. Deb DK, Chen Y, Zhang Z, Zhang Y, Szeto FL, Wong KE, Kong J, Li YC 2009 1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-kB pathway. Am J Physiol Renal Physiol 296:F1212-F1218
34. Kendrick J, Targher G, Smits G, Chonchol M 2009 25-Hydroxyvi-tamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 205:255-260
35. Scragg R, Sowers M, Bell C 2007 Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 20:713-719
36. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R, Norris K 2007 Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 167:1159-1165
37. Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Korfer R, Stehle P 2003 Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 41:105-112
38. Giovannucci E, Liu Y, Hollis BW, Rimm EB 2008 25-hydroxyvi-tamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168:1174-1180
39. Kovesdy CP 2010 Survival benefits with vitamin D receptor activation: new insights since 2003. Clin J Am Soc Nephrol 5:1704-1709
40. Iwai N, Izumi M, Inagami T, Kinoshita M 1997 Induction of renin in medial smooth muscle cells by balloon injury. Hypertension 29: 1044-1050
41. Campbell DJ, Habener JF 1986 Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest 78:31-39
42. Hellmann W, Suzuki F, Ohkubo H, Nakanishi S, Ludwig G, Ganten D 1988 Angiotensinogen gene expression in extrahepatic rat tissues: application of a solution hybridization assay. Naunyn Schmie-debergs Arch Pharmacol 338:327-331
43. Falkenhahn M, Franke F, Bohle RM, Zhu YC, Stauss HM, Bach-mann S, Danilov S, Unger T 1995 Cellular distribution of angio-tensin-converting enzyme after myocardial infarction. Hypertension 25:219-226
44. Fernandez-Alfonso MS, Martorana PA, Licka I, van Even P, Tro-bisch D, Scholkens BA, Paul M 1997 Early induction of angiotensin I-converting enzyme in rat carotid artery after balloon injury. Hypertension 30:272-277
45. Diet F, Pratt RE, Berry GJ, Momose N, Gibbons GH, Dzau VJ 1996 Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 94:2756-2767
46. Ohishi M, Ueda M, Rakugi H, Naruko T, Kojima A, Okamura A, Higaki J, Ogihara T 1997 Enhanced expression of angiotensin-converting enzyme is associated with progression of coronary atherosclerosis in humans. J Hypertens 15:1295-1302
47. Daugherty A, Cassis L 2004 Angiotensin II-mediated development of vascular diseases. Trends Cardiovasc Med 14:117-120
48. Daugherty A, Manning MW, Cassis LA 2000 Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 105:1605-1612
49. Sata M, Fukuda D 2010 Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis. J Med Invest 57:12-25
50. Harrison DG 1997 Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 100:2153-2157
51. Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, Arnal JF, Michel JB 2000 Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-KB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol 20:645-651
52. Pastore L, Tessitore A, Martinotti S, Toniato E, Alesse E, Bravi MC, Ferri C, Desideri G, Gulino A, Santucci A 1999 Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo. Circulation 100:1646-1652
53. Tummala PE, Chen XL, Sundell CL, Laursen JB, Hammes CP, Alexander RW, Harrison DG, Medford RM 1999 Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis. Circulation 100:1223-1229
54. Hernandez-Presa M, Bustos C, Ortego M, Tuñon J, Renedo G, Ruiz-Ortega M, Egido J 1997 Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-K B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 95:1532-1541
55. Keidar S, Heinrich R, Kaplan M, Hayek T, Aviram M 2001 Angiotensin II administration to atherosclerotic mice increases macrophage uptake of oxidized ldl: a possible role for interleukin-6. Arterioscler Thromb Vasc Biol 21:1464-1469
56. Han Y, Runge MS, Brasier AR 1999 Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-K B transcription factors. Circ Res 84:695-703
57. Brasier AR, Jamaluddin M, Han Y, Patterson C, Runge MS 2000 Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-«B (NF-kB) transcription factor. Mol Cell Biochem 212:155-169
58. Ikeda U, Ikeda M, Oohara T, Oguchi A, Kamitani T, Tsuruya Y, Kano S 1991 Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am J Physiol 260: H1713-H1717
59. Galis ZS, Khatri JJ 2002 Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90:251-262
60. Chen J, Li D, Schaefer RF, Mehta JL 2004 Inhibitory effect of candesartan and rosuvastatin on CD40 and MMPs expression in apo-E knockout mice: novel insights into the role of RAS and dys-lipidemia in atherogenesis. J Cardiovasc Pharmacol 44:446-452
61. Han S, Chiang JY 2009 Mechanism of vitamin D receptor inhibition of cholesterol 7a-hydroxylase gene transcription in human hepatocytes. Drug Metab Dispos 37:469-478
62. Schmidt DR, Holmstrom SR, Fon Tacer K, Bookout AL, Kliewer SA, Mangelsdorf DJ 2010 Regulation of bile acid synthesis by fat-soluble vitamins A and D. J Biol Chem 285:14486-14494